The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR)

Thursday, November 08, 2012

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR)17:04 EST Thursday, November 08, 2012NEW YORK, Nov. 8, 2012 /PRNewswire/ -- DUSA Pharmaceuticals Inc. Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )Schiff Nutrition International, Inc. Levi & Korsinsky is investigating the Board of Directors of Schiff Nutrition International, Inc. (NYSE: SHF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bayer HealthCare, LLC for $34 per share. Click here to learn more about the investigation: http://zlk.9nl.com/shiff-nutrition-international-shf, or call: 877-363-5972.The Warnaco Group, Inc. Levi & Korsinsky is investigating the Board of Directors of The Warnaco Group, Inc. (NYSE: WRC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PVH Corp. under which shareholders will receive $51.75 in cash and 0.1822 of a PVH common share per share. Click here to learn more about the investigation http://zlk.9nl.com/warnaco-group-wrc, or call: 877-363-5972.Questcor Pharmaceuticals, Inc. Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.   Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:      Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor  New York, NY 10004 Tel: (212) 363-7500 Toll Free:  (877) 363-5972 Fax: (212) 363-7171 www.zlk.comSOURCE Levi & Korsinsky, LLP